Celsius Holdings, Inc.
Business
Celsius Holdings, Inc. is a functional energy drink company that develops, processes, markets, manufactures and distributes functional energy beverages and related products for a broad consumer base, including fitness enthusiasts. Its main product portfolio includes CELSIUS® ready-to-drink 12-ounce cans, on-the-go powders, CELSIUS ESSENTIALS™ 16-ounce beverages and CELSIUS® Hydration zero-sugar powders, formulated using its proprietary MetaPlus® blend. The company operates through product development and R&D, co-packing and in-house manufacturing, an international hub for supply-chain and IP, and strategic distribution partnerships. Celsius sells through U.S. and international retail channels — supermarkets, convenience and drug stores, fitness outlets, mass merchants and e-commerce — and distributes via direct-store delivery, independent distributors and major partners such as Pepsi and regional distributors.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 2,515 | 1,356 | 1,318 | 654 | — | |
| Cost of revenue | 1,248 | 675 | 685 | 383 | — | |
| Gross profit | 1,267 | 680 | 633 | 271 | 128 | |
| Selling, general and administrative expenses | 799 | 524 | 367 | 429 | — | |
| Distributor termination fees | 327 | 0 | 0 | — | — | |
| Income from operations | 141 | 156 | 266 | −158 | −4 | |
| Interest income | 21 | 39 | 27 | 5 | −8,000 | |
| Interest expense | −49 | 0 | 0 | — | — | |
| Other, net | 12 | 59,000 | −1 | 0 | — | |
| Total other (expense) income | −16 | 39 | 25 | 5 | 31,000 | |
| Net income before provision for income taxes | 125 | 195 | 292 | −153 | −4 | |
| Provision for income taxes | −17 | −50 | −65 | −35 | 8 | |
| Net income | 108 | 145 | 227 | −187 | 4 | |
| Dividends on convertible preferred stock | −38 | −28 | −27 | −12 | 0 | |
| Income allocated to participating preferred stock | −7 | −10 | −17 | 0 | 0 | |
| Net income attributable to common stockholders | 64 | 107 | 182 | −199 | 4 | |
| Foreign currency translation | 6 | −3 | 1 | — | — | |
| Comprehensive income | 70 | 105 | 183 | −201 | 5 | |
| Basic (in USD per share) | 0.25 | 0.46 | 0.79 | −0.88 | 0.02 | |
| Diluted (in USD per share) | 0.25 | 0.45 | 0.77 | −0.88 | 0.02 | |
| Basic (in shares) | 252 | 234 | 231 | 227 | 221 | |
| Diluted (in shares) | 255 | 237 | 237 | 227 | 233 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 399 | 890 | 756 | 614 | 16 | |
| Restricted cash | 141 | 0 | 0 | 39 | 0 | |
| Accounts receivable-net | 755 | 270 | 184 | 63 | 39 | |
| Inventories-net | 338 | 131 | 229 | 173 | 191 | |
| Prepaid expenses and other current assets | 129 | 19 | 20 | 11 | 14 | |
| Deferred other costs-current | 49 | 14 | — | — | — | |
| Total current assets | 1,811 | 1,325 | 1,205 | 918 | 262 | |
| Property, plant and equipment-net | 88 | 56 | 25 | 10 | 3 | |
| Goodwill | 918 | 72 | 14 | 14 | 15 | |
| Deferred other costs-non-current | 772 | 234 | 248 | 262 | 0 | |
| Deferred tax assets | 96 | 39 | 30 | 501,000 | 9 | |
| Other long-term assets | 43 | 30 | 291,000 | — | — | |
| Total Assets | 5,120 | 1,767 | 1,536 | 1,222 | 314 | |
| Accounts payable | 138 | 41 | 43 | 36 | — | |
| Accrued expenses | 231 | 149 | 62 | 70 | — | |
| Income taxes payable | 50 | 11 | 50 | 1 | — | |
| Accrued distributor termination fees | 264 | 0 | — | — | — | |
| Accrued promotional allowance | 308 | 136 | 100 | 36 | 19 | |
| Contingent consideration | 25 | 0 | — | — | — | |
| Deferred revenue-current | 27 | 10 | 10 | — | — | |
| Other current liabilities | 36 | 19 | 11 | 4 | 976,000 | |
| Total current liabilities | 1,079 | 366 | 277 | 161 | 93 | |
| Long-term debt | 670 | 0 | — | — | — | |
| Deferred revenue-non-current | 401 | 158 | 167 | — | — | |
| Other long term liabilities | 28 | 19 | — | — | — | |
| Total Liabilities | 2,178 | 542 | 448 | 357 | 97 | |
| Commitments and contingencies (Note 17) | — | — | — | — | — | |
| Common Stock, $0.001 par value per share; 400,000 shares authorized; 258,108 shares issued and 256,906 shares outstanding as of December 31, 2025; and 235,087 shares issued and 235,014 shares outstanding as of December 31, 2024. | 101,000 | 79,000 | 77,000 | 76,000 | 75,000 | |
| Treasury stock, at cost; 1,202 shares and 73 shares as of December 31, 2025 and 2024, respectively | −48 | −3 | — | — | — | |
| Additional paid-in capital | 1,051 | 300 | 277 | 281 | 268 | |
| Accumulated other comprehensive income (loss) | 3 | −3 | −701,000 | −2 | 614,000 | |
| Retained earnings | 176 | 106 | −12 | −239 | −52 | |
| Total Stockholders Equity | 1,181 | 400 | 264 | 40 | 217 | |
| Total Liabilities, Mezzanine Equity and Stockholders Equity | 5,120 | 1,767 | 1,536 | 1,222 | 314 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 29 | 7 | 3 | 2 | 1 | |
| Allowance for credit losses | 11 | 3 | 2 | 2 | 1 | |
| Amortization of deferred other costs | 26 | 14 | 14 | 6 | 0 | |
| Inventory excess and obsolescence | 29 | 19 | 7 | 6 | 2 | |
| Stock-based compensation expense | 28 | 20 | 21 | 21 | 36 | |
| Deferred income taxes-net | −57 | −10 | −42 | 20 | — | |
| Change in fair value of contingent consideration | 14 | 0 | 0 | — | — | |
| Loss on debt extinguishment | 6 | 0 | 0 | — | — | |
| Other operating activities-net | −2 | 2 | 1 | 0 | — | |
| Accounts and note receivable-net | −412 | −87 | −122 | — | — | |
| Inventories | −130 | 77 | −63 | 12 | −175 | |
| Prepaid expenses and other current assets | −108 | 1 | −8 | 2 | 1 | |
| Other long-term assets | 3 | −5 | −28,000 | 37,000 | — | |
| Accounts payable | 51 | −1 | 5 | 428,000 | 24 | |
| Accrued expenses | 46 | 85 | −8 | 35 | 26 | |
| Income taxes payable | 39 | −40 | 48 | −164,000 | 1 | |
| Accrued promotional allowance | 154 | 36 | 64 | 17 | 13 | |
| Accrued distributor termination fees | 258 | −248,000 | −4 | — | — | |
| Other current liabilities | 10 | 5 | 7 | 3 | 374,000 | |
| Deferred revenue | 255 | −10 | −13 | 189 | 0 | |
| Other long-term liabilities | 2 | 535,000 | −102,000 | 189 | 0 | |
| Net cash provided by operating activities | 359 | 263 | 141 | 108 | −97 | |
| Collections from note receivable | 0 | 0 | 3 | 3 | — | |
| Purchase of property, plant and equipment | −36 | −23 | −17 | −8 | −3 | |
| Purchase of non-marketable equity securities | −10 | −3 | 0 | 0 | — | |
| Net working capital estimate received from Pepsi related to the Rockstar Acquisition | 29 | 0 | 0 | — | — | |
| Net cash used in investing activities | −1,296 | −102 | −14 | −6 | −1 | |
| Cash dividends paid on preferred stock | −38 | −28 | −27 | −12 | 0 | |
| Repurchase of Common Stock related to employee tax withholdings | −6 | −2 | 0 | 0 | — | |
| Repurchase of Common Stock for Treasury | −40 | 0 | 0 | — | — | |
| Proceeds from term loan | 900 | 0 | 0 | — | — | |
| Payments on term loan | −202 | 0 | 0 | — | — | |
| Payment of debt issuance costs and debt discount | −30 | 0 | 0 | — | — | |
| Payment of revolver fees | −3 | 0 | 0 | — | — | |
| Other financing activities-net | −7,000 | 4 | 2 | 0 | 0 | |
| Net cash provided by (used in) financing activities | 583 | −26 | −25 | 534 | 71 | |
| Effect on exchange rate changes on cash, cash equivalents and restricted cash | 3 | −997,000 | 1 | 50,000 | −538,000 | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | −350 | 134 | 103 | 637 | −27 | |
| Interest | 46 | 0 | 0 | 0 | 7,000 | |
| Taxes, net of refunds received | 64 | 99 | 57 | — | — | |
| Acquisition date fair value of Alani Nu contingent consideration | 11 | 0 | 0 | — | — | |
| Fair value of Series A Preferred Stock modification | 28 | 0 | 0 | — | — |